LAIDX
Price
$11.78
Change
+$0.05 (+0.43%)
Updated
Jun 2 closing price
Net Assets
531.9M
TRWTX
Price
$28.36
Change
+$0.17 (+0.60%)
Updated
Jun 2 closing price
Net Assets
4.32B
Interact to see
Advertisement

LAIDX vs TRWTX

Header iconLAIDX vs TRWTX Comparison
Open Charts LAIDX vs TRWTXBanner chart's image
LAIDX vs TRWTX Comparison Chart in %
View a ticker or compare two or three
VS
LAIDX vs. TRWTX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LAIDX is a Buy and TRWTX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
TRWTX has more cash in the bank: 4.32B vs. LAIDX (532M). TRWTX pays higher dividends than LAIDX: TRWTX (3.44) vs LAIDX (2.71). LAIDX was incepted earlier than TRWTX: LAIDX (18 years) vs TRWTX (33 years). TRWTX (0.76) and LAIDX (0.73) have similar cost to investors . LAIDX is a more actively managed with annual turnover of: 66.00 vs. TRWTX (13.00). TRWTX has a lower initial minimum investment than LAIDX: TRWTX (0) vs LAIDX (1000000). LAIDX annual gain was more profitable for investors over the last year : 26.88 vs. TRWTX (20.68). LAIDX return over 5 years is better than : 57.06 vs. TRWTX (46.23).
LAIDXTRWTXLAIDX / TRWTX
Total Expense Ratio0.730.7696%
Annual Report Gross Expense Ratio0.730.7696%
Fund Existence18 years33 years-
Gain YTD10.88811.99891%
Front LoadN/AN/A-
Min. Initial Investment10000000-
Min. Initial Investment IRAN/AN/A-
Net Assets532M4.32B12%
Annual Yield % from dividends2.713.4479%
Returns for 1 year26.8820.68130%
Returns for 3 years78.3157.37137%
Returns for 5 years57.0646.23123%
Returns for 10 years117.02104.63112%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SYNA146.0911.16
+8.27%
Synaptics
ROST223.78-0.29
-0.13%
Ross Stores
LCNB16.56-0.09
-0.54%
LCNB Corp
TDAY7.79-0.37
-4.53%
USA TODAY Co. Inc.
HOWL0.43-0.04
-7.64%
Werewolf Therapeutics